nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A1—lung cancer	0.255	0.653	CbGaD
Toremifene—ABCB1—lung cancer	0.135	0.347	CbGaD
Toremifene—CYP1A1—Gefitinib—lung cancer	0.0565	0.143	CbGbCtD
Toremifene—CYP1A1—Erlotinib—lung cancer	0.0334	0.0846	CbGbCtD
Toremifene—ABCB1—Topotecan—lung cancer	0.0241	0.0611	CbGbCtD
Toremifene—ABCB1—Gefitinib—lung cancer	0.0221	0.0559	CbGbCtD
Toremifene—ABCB1—Vinorelbine—lung cancer	0.017	0.043	CbGbCtD
Toremifene—CYP1A2—Erlotinib—lung cancer	0.0149	0.0378	CbGbCtD
Toremifene—CYP3A4—Topotecan—lung cancer	0.0145	0.0366	CbGbCtD
Toremifene—ABCB1—Crizotinib—lung cancer	0.0135	0.0342	CbGbCtD
Toremifene—CYP3A4—Gefitinib—lung cancer	0.0132	0.0335	CbGbCtD
Toremifene—ABCB1—Gemcitabine—lung cancer	0.0132	0.0335	CbGbCtD
Toremifene—ABCB1—Erlotinib—lung cancer	0.0131	0.033	CbGbCtD
Toremifene—CYP3A4—Teniposide—lung cancer	0.0128	0.0325	CbGbCtD
Toremifene—ABCB1—Paclitaxel—lung cancer	0.012	0.0302	CbGbCtD
Toremifene—ABCB1—Irinotecan—lung cancer	0.0118	0.0298	CbGbCtD
Toremifene—CYP1A2—Etoposide—lung cancer	0.0108	0.0273	CbGbCtD
Toremifene—ABCB1—Vinblastine—lung cancer	0.0105	0.0265	CbGbCtD
Toremifene—CYP3A4—Vinorelbine—lung cancer	0.0102	0.0258	CbGbCtD
Toremifene—ABCB1—Cisplatin—lung cancer	0.00961	0.0243	CbGbCtD
Toremifene—ABCB1—Etoposide—lung cancer	0.00945	0.0239	CbGbCtD
Toremifene—ABCB1—Docetaxel—lung cancer	0.00864	0.0219	CbGbCtD
Toremifene—CYP3A4—Crizotinib—lung cancer	0.00811	0.0205	CbGbCtD
Toremifene—CYP3A4—Erlotinib—lung cancer	0.00782	0.0198	CbGbCtD
Toremifene—CYP3A4—Paclitaxel—lung cancer	0.00716	0.0181	CbGbCtD
Toremifene—CYP3A4—Irinotecan—lung cancer	0.00707	0.0179	CbGbCtD
Toremifene—ABCB1—Doxorubicin—lung cancer	0.00644	0.0163	CbGbCtD
Toremifene—CYP3A4—Vinblastine—lung cancer	0.00628	0.0159	CbGbCtD
Toremifene—ABCB1—Methotrexate—lung cancer	0.00624	0.0158	CbGbCtD
Toremifene—CYP3A4—Etoposide—lung cancer	0.00566	0.0143	CbGbCtD
Toremifene—CYP3A4—Docetaxel—lung cancer	0.00518	0.0131	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—lung cancer	0.00386	0.00977	CbGbCtD
Toremifene—Loperamide—POMC—lung cancer	0.000698	0.285	CrCbGaD
Toremifene—Clomifene—CYP2A6—lung cancer	0.000347	0.142	CrCbGaD
Toremifene—Clomifene—CYP2E1—lung cancer	0.000247	0.101	CrCbGaD
Toremifene—Clomifene—CYP1A1—lung cancer	0.000243	0.0994	CrCbGaD
Toremifene—Tamoxifen—CYP2A6—lung cancer	0.00016	0.0655	CrCbGaD
Toremifene—Tamoxifen—ABCG2—lung cancer	0.000144	0.0586	CrCbGaD
Toremifene—Oedema—Gemcitabine—lung cancer	0.000134	0.000975	CcSEcCtD
Toremifene—Hyperhidrosis—Irinotecan—lung cancer	0.000133	0.000968	CcSEcCtD
Toremifene—Back pain—Paclitaxel—lung cancer	0.000133	0.000968	CcSEcCtD
Toremifene—Dizziness—Vinblastine—lung cancer	0.000133	0.000966	CcSEcCtD
Toremifene—Mood swings—Methotrexate—lung cancer	0.000132	0.000961	CcSEcCtD
Toremifene—Nervous system disorder—Gemcitabine—lung cancer	0.000131	0.000956	CcSEcCtD
Toremifene—Thrombocytopenia—Gemcitabine—lung cancer	0.000131	0.000955	CcSEcCtD
Toremifene—Anorexia—Irinotecan—lung cancer	0.000131	0.000954	CcSEcCtD
Toremifene—Ataxia—Methotrexate—lung cancer	0.000131	0.000954	CcSEcCtD
Toremifene—Skin disorder—Gemcitabine—lung cancer	0.00013	0.000947	CcSEcCtD
Toremifene—Vision blurred—Paclitaxel—lung cancer	0.000129	0.000943	CcSEcCtD
Toremifene—Hyperhidrosis—Gemcitabine—lung cancer	0.000129	0.000943	CcSEcCtD
Toremifene—Clomifene—ABCB1—lung cancer	0.000129	0.0528	CrCbGaD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000129	0.000942	CcSEcCtD
Toremifene—Hot flush—Doxorubicin—lung cancer	0.000129	0.000939	CcSEcCtD
Toremifene—Visual impairment—Docetaxel—lung cancer	0.000129	0.000939	CcSEcCtD
Toremifene—Dizziness—Topotecan—lung cancer	0.000129	0.000938	CcSEcCtD
Toremifene—Tremor—Paclitaxel—lung cancer	0.000129	0.000937	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—lung cancer	0.000129	0.000937	CcSEcCtD
Toremifene—Menopausal symptoms—Doxorubicin—lung cancer	0.000128	0.000931	CcSEcCtD
Toremifene—Anorexia—Gemcitabine—lung cancer	0.000128	0.00093	CcSEcCtD
Toremifene—Vomiting—Vinblastine—lung cancer	0.000127	0.000929	CcSEcCtD
Toremifene—Dizziness—Erlotinib—lung cancer	0.000127	0.000928	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—lung cancer	0.000126	0.000917	CcSEcCtD
Toremifene—Vertigo—Etoposide—lung cancer	0.000126	0.000917	CcSEcCtD
Toremifene—Headache—Vinblastine—lung cancer	0.000126	0.000915	CcSEcCtD
Toremifene—Leukopenia—Etoposide—lung cancer	0.000125	0.000913	CcSEcCtD
Toremifene—Eye disorder—Docetaxel—lung cancer	0.000125	0.00091	CcSEcCtD
Toremifene—Oedema—Cisplatin—lung cancer	0.000125	0.000909	CcSEcCtD
Toremifene—Insomnia—Irinotecan—lung cancer	0.000124	0.000906	CcSEcCtD
Toremifene—Vomiting—Topotecan—lung cancer	0.000124	0.000902	CcSEcCtD
Toremifene—Cardiac failure—Doxorubicin—lung cancer	0.000124	0.0009	CcSEcCtD
Toremifene—Vertigo—Paclitaxel—lung cancer	0.000123	0.000899	CcSEcCtD
Toremifene—Lethargy—Doxorubicin—lung cancer	0.000123	0.000897	CcSEcCtD
Toremifene—Leukopenia—Paclitaxel—lung cancer	0.000123	0.000896	CcSEcCtD
Toremifene—Rash—Topotecan—lung cancer	0.000123	0.000895	CcSEcCtD
Toremifene—Dermatitis—Topotecan—lung cancer	0.000123	0.000894	CcSEcCtD
Toremifene—Vomiting—Erlotinib—lung cancer	0.000122	0.000893	CcSEcCtD
Toremifene—Dyspnoea—Irinotecan—lung cancer	0.000122	0.000893	CcSEcCtD
Toremifene—Nervous system disorder—Cisplatin—lung cancer	0.000122	0.000891	CcSEcCtD
Toremifene—Thrombocytopenia—Cisplatin—lung cancer	0.000122	0.00089	CcSEcCtD
Toremifene—Headache—Topotecan—lung cancer	0.000122	0.000889	CcSEcCtD
Toremifene—Rash—Erlotinib—lung cancer	0.000121	0.000885	CcSEcCtD
Toremifene—Dermatitis—Erlotinib—lung cancer	0.000121	0.000884	CcSEcCtD
Toremifene—Angiopathy—Docetaxel—lung cancer	0.000121	0.000884	CcSEcCtD
Toremifene—Skin disorder—Cisplatin—lung cancer	0.000121	0.000883	CcSEcCtD
Toremifene—Insomnia—Gemcitabine—lung cancer	0.000121	0.000882	CcSEcCtD
Toremifene—Headache—Erlotinib—lung cancer	0.000121	0.00088	CcSEcCtD
Toremifene—Diplopia—Doxorubicin—lung cancer	0.000121	0.000879	CcSEcCtD
Toremifene—Hyperhidrosis—Cisplatin—lung cancer	0.000121	0.000879	CcSEcCtD
Toremifene—Mediastinal disorder—Docetaxel—lung cancer	0.00012	0.000878	CcSEcCtD
Toremifene—Chills—Docetaxel—lung cancer	0.00012	0.000874	CcSEcCtD
Toremifene—Asthenia—Vinorelbine—lung cancer	0.000119	0.000871	CcSEcCtD
Toremifene—Decreased appetite—Irinotecan—lung cancer	0.000119	0.00087	CcSEcCtD
Toremifene—Arrhythmia—Docetaxel—lung cancer	0.000119	0.00087	CcSEcCtD
Toremifene—Dyspnoea—Gemcitabine—lung cancer	0.000119	0.000869	CcSEcCtD
Toremifene—Chest pain—Etoposide—lung cancer	0.000119	0.000869	CcSEcCtD
Toremifene—Nausea—Vinblastine—lung cancer	0.000119	0.000868	CcSEcCtD
Toremifene—Anorexia—Cisplatin—lung cancer	0.000119	0.000866	CcSEcCtD
Toremifene—Affect lability—Doxorubicin—lung cancer	0.000119	0.000865	CcSEcCtD
Toremifene—Gastrointestinal disorder—Irinotecan—lung cancer	0.000119	0.000864	CcSEcCtD
Toremifene—Fatigue—Irinotecan—lung cancer	0.000118	0.000863	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000118	0.000863	CcSEcCtD
Toremifene—Alopecia—Docetaxel—lung cancer	0.000118	0.000861	CcSEcCtD
Toremifene—Pruritus—Vinorelbine—lung cancer	0.000118	0.000859	CcSEcCtD
Toremifene—Pain—Irinotecan—lung cancer	0.000117	0.000856	CcSEcCtD
Toremifene—Constipation—Irinotecan—lung cancer	0.000117	0.000856	CcSEcCtD
Toremifene—Mental disorder—Docetaxel—lung cancer	0.000117	0.000853	CcSEcCtD
Toremifene—Chest pain—Paclitaxel—lung cancer	0.000117	0.000852	CcSEcCtD
Toremifene—Malnutrition—Docetaxel—lung cancer	0.000116	0.000848	CcSEcCtD
Toremifene—Decreased appetite—Gemcitabine—lung cancer	0.000116	0.000848	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000116	0.000846	CcSEcCtD
Toremifene—Nausea—Topotecan—lung cancer	0.000116	0.000843	CcSEcCtD
Toremifene—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000116	0.000842	CcSEcCtD
Toremifene—Fatigue—Gemcitabine—lung cancer	0.000115	0.000841	CcSEcCtD
Toremifene—Pain—Gemcitabine—lung cancer	0.000114	0.000834	CcSEcCtD
Toremifene—Constipation—Gemcitabine—lung cancer	0.000114	0.000834	CcSEcCtD
Toremifene—Nausea—Erlotinib—lung cancer	0.000114	0.000834	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—lung cancer	0.000114	0.000832	CcSEcCtD
Toremifene—Tamoxifen—CYP2E1—lung cancer	0.000114	0.0465	CrCbGaD
Toremifene—Ataxia—Doxorubicin—lung cancer	0.000113	0.000826	CcSEcCtD
Toremifene—Back pain—Docetaxel—lung cancer	0.000113	0.00082	CcSEcCtD
Toremifene—Tamoxifen—CYP1A1—lung cancer	0.000112	0.0459	CrCbGaD
Toremifene—Oedema—Paclitaxel—lung cancer	0.000112	0.000817	CcSEcCtD
Toremifene—Thrombocytopenia—Etoposide—lung cancer	0.000112	0.000815	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—lung cancer	0.000111	0.000811	CcSEcCtD
Toremifene—Dyspnoea—Cisplatin—lung cancer	0.000111	0.00081	CcSEcCtD
Toremifene—Skin disorder—Etoposide—lung cancer	0.000111	0.000809	CcSEcCtD
Toremifene—Orphenadrine—CYP2E1—lung cancer	0.000111	0.0452	CrCbGaD
Toremifene—Hyperhidrosis—Etoposide—lung cancer	0.00011	0.000805	CcSEcCtD
Toremifene—Dizziness—Vinorelbine—lung cancer	0.00011	0.000803	CcSEcCtD
Toremifene—Nervous system disorder—Paclitaxel—lung cancer	0.00011	0.000801	CcSEcCtD
Toremifene—Thrombocytopenia—Paclitaxel—lung cancer	0.00011	0.000799	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—lung cancer	0.000109	0.000794	CcSEcCtD
Toremifene—Anorexia—Etoposide—lung cancer	0.000109	0.000794	CcSEcCtD
Toremifene—Skin disorder—Paclitaxel—lung cancer	0.000109	0.000793	CcSEcCtD
Toremifene—Decreased appetite—Cisplatin—lung cancer	0.000108	0.00079	CcSEcCtD
Toremifene—Hyperhidrosis—Paclitaxel—lung cancer	0.000108	0.000789	CcSEcCtD
Toremifene—Gastrointestinal disorder—Cisplatin—lung cancer	0.000108	0.000785	CcSEcCtD
Toremifene—Anorexia—Paclitaxel—lung cancer	0.000107	0.000778	CcSEcCtD
Toremifene—Pain—Cisplatin—lung cancer	0.000107	0.000777	CcSEcCtD
Toremifene—Vomiting—Vinorelbine—lung cancer	0.000106	0.000772	CcSEcCtD
Toremifene—Rash—Vinorelbine—lung cancer	0.000105	0.000765	CcSEcCtD
Toremifene—Dermatitis—Vinorelbine—lung cancer	0.000105	0.000765	CcSEcCtD
Toremifene—Headache—Vinorelbine—lung cancer	0.000104	0.00076	CcSEcCtD
Toremifene—Leukopenia—Docetaxel—lung cancer	0.000104	0.000759	CcSEcCtD
Toremifene—Sweating—Methotrexate—lung cancer	0.000103	0.00075	CcSEcCtD
Toremifene—Dyspnoea—Etoposide—lung cancer	0.000102	0.000742	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—lung cancer	0.000102	0.00074	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—lung cancer	0.000101	0.00074	CcSEcCtD
Toremifene—Insomnia—Paclitaxel—lung cancer	0.000101	0.000738	CcSEcCtD
Toremifene—Dyspnoea—Paclitaxel—lung cancer	9.99e-05	0.000728	CcSEcCtD
Toremifene—Decreased appetite—Etoposide—lung cancer	9.93e-05	0.000724	CcSEcCtD
Toremifene—Chest pain—Docetaxel—lung cancer	9.9e-05	0.000722	CcSEcCtD
Toremifene—Nausea—Vinorelbine—lung cancer	9.89e-05	0.000721	CcSEcCtD
Toremifene—Gastrointestinal disorder—Etoposide—lung cancer	9.86e-05	0.000719	CcSEcCtD
Toremifene—Asthenia—Irinotecan—lung cancer	9.85e-05	0.000718	CcSEcCtD
Toremifene—Fatigue—Etoposide—lung cancer	9.85e-05	0.000718	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.84e-05	0.000717	CcSEcCtD
Toremifene—Constipation—Etoposide—lung cancer	9.77e-05	0.000712	CcSEcCtD
Toremifene—Pain—Etoposide—lung cancer	9.77e-05	0.000712	CcSEcCtD
Toremifene—Decreased appetite—Paclitaxel—lung cancer	9.74e-05	0.00071	CcSEcCtD
Toremifene—Gastrointestinal disorder—Paclitaxel—lung cancer	9.67e-05	0.000705	CcSEcCtD
Toremifene—Fatigue—Paclitaxel—lung cancer	9.66e-05	0.000704	CcSEcCtD
Toremifene—Asthenia—Gemcitabine—lung cancer	9.6e-05	0.0007	CcSEcCtD
Toremifene—Pain—Paclitaxel—lung cancer	9.58e-05	0.000698	CcSEcCtD
Toremifene—Constipation—Paclitaxel—lung cancer	9.58e-05	0.000698	CcSEcCtD
Toremifene—Oedema—Docetaxel—lung cancer	9.49e-05	0.000692	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—lung cancer	9.48e-05	0.000691	CcSEcCtD
Toremifene—Pruritus—Gemcitabine—lung cancer	9.47e-05	0.00069	CcSEcCtD
Toremifene—Nervous system disorder—Docetaxel—lung cancer	9.31e-05	0.000679	CcSEcCtD
Toremifene—Thrombocytopenia—Docetaxel—lung cancer	9.3e-05	0.000678	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—lung cancer	9.28e-05	0.000677	CcSEcCtD
Toremifene—Skin disorder—Docetaxel—lung cancer	9.22e-05	0.000672	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—lung cancer	9.11e-05	0.000664	CcSEcCtD
Toremifene—Dizziness—Irinotecan—lung cancer	9.08e-05	0.000662	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—lung cancer	9.06e-05	0.00066	CcSEcCtD
Toremifene—Anorexia—Docetaxel—lung cancer	9.05e-05	0.00066	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—lung cancer	9e-05	0.000656	CcSEcCtD
Toremifene—Asthenia—Cisplatin—lung cancer	8.95e-05	0.000652	CcSEcCtD
Toremifene—Sweating—Doxorubicin—lung cancer	8.91e-05	0.000649	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—lung cancer	8.79e-05	0.00064	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—lung cancer	8.74e-05	0.000637	CcSEcCtD
Toremifene—Vomiting—Irinotecan—lung cancer	8.73e-05	0.000637	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—lung cancer	8.68e-05	0.000633	CcSEcCtD
Toremifene—Rash—Irinotecan—lung cancer	8.66e-05	0.000631	CcSEcCtD
Toremifene—Dermatitis—Irinotecan—lung cancer	8.65e-05	0.000631	CcSEcCtD
Toremifene—Chills—Methotrexate—lung cancer	8.64e-05	0.00063	CcSEcCtD
Toremifene—Headache—Irinotecan—lung cancer	8.6e-05	0.000627	CcSEcCtD
Toremifene—Insomnia—Docetaxel—lung cancer	8.59e-05	0.000626	CcSEcCtD
Toremifene—Alopecia—Methotrexate—lung cancer	8.51e-05	0.00062	CcSEcCtD
Toremifene—Vomiting—Gemcitabine—lung cancer	8.51e-05	0.00062	CcSEcCtD
Toremifene—Dyspnoea—Docetaxel—lung cancer	8.47e-05	0.000617	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—lung cancer	8.44e-05	0.000615	CcSEcCtD
Toremifene—Rash—Gemcitabine—lung cancer	8.44e-05	0.000615	CcSEcCtD
Toremifene—Dermatitis—Gemcitabine—lung cancer	8.43e-05	0.000614	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—lung cancer	8.39e-05	0.000611	CcSEcCtD
Toremifene—Headache—Gemcitabine—lung cancer	8.38e-05	0.000611	CcSEcCtD
Toremifene—Loperamide—ABCB1—lung cancer	8.32e-05	0.034	CrCbGaD
Toremifene—Decreased appetite—Docetaxel—lung cancer	8.25e-05	0.000602	CcSEcCtD
Toremifene—Gastrointestinal disorder—Docetaxel—lung cancer	8.2e-05	0.000597	CcSEcCtD
Toremifene—Asthenia—Etoposide—lung cancer	8.2e-05	0.000597	CcSEcCtD
Toremifene—Fatigue—Docetaxel—lung cancer	8.19e-05	0.000597	CcSEcCtD
Toremifene—Nausea—Irinotecan—lung cancer	8.16e-05	0.000595	CcSEcCtD
Toremifene—Pain—Docetaxel—lung cancer	8.12e-05	0.000592	CcSEcCtD
Toremifene—Constipation—Docetaxel—lung cancer	8.12e-05	0.000592	CcSEcCtD
Toremifene—Back pain—Methotrexate—lung cancer	8.11e-05	0.000591	CcSEcCtD
Toremifene—Pruritus—Etoposide—lung cancer	8.08e-05	0.000589	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—lung cancer	8.04e-05	0.000586	CcSEcCtD
Toremifene—Asthenia—Paclitaxel—lung cancer	8.04e-05	0.000586	CcSEcCtD
Toremifene—Nausea—Gemcitabine—lung cancer	7.95e-05	0.000579	CcSEcCtD
Toremifene—Vomiting—Cisplatin—lung cancer	7.93e-05	0.000578	CcSEcCtD
Toremifene—Pruritus—Paclitaxel—lung cancer	7.93e-05	0.000578	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—lung cancer	7.9e-05	0.000576	CcSEcCtD
Toremifene—Rash—Cisplatin—lung cancer	7.86e-05	0.000573	CcSEcCtD
Toremifene—Dermatitis—Cisplatin—lung cancer	7.86e-05	0.000573	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—lung cancer	7.79e-05	0.000568	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—lung cancer	7.57e-05	0.000552	CcSEcCtD
Toremifene—Dizziness—Etoposide—lung cancer	7.56e-05	0.000551	CcSEcCtD
Toremifene—Vertigo—Methotrexate—lung cancer	7.53e-05	0.000549	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—lung cancer	7.52e-05	0.000548	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—lung cancer	7.51e-05	0.000547	CcSEcCtD
Toremifene—Chills—Doxorubicin—lung cancer	7.48e-05	0.000545	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—lung cancer	7.45e-05	0.000543	CcSEcCtD
Toremifene—Dizziness—Paclitaxel—lung cancer	7.41e-05	0.00054	CcSEcCtD
Toremifene—Nausea—Cisplatin—lung cancer	7.41e-05	0.00054	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—lung cancer	7.37e-05	0.000537	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—lung cancer	7.31e-05	0.000533	CcSEcCtD
Toremifene—Vomiting—Etoposide—lung cancer	7.26e-05	0.000529	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—lung cancer	7.26e-05	0.000529	CcSEcCtD
Toremifene—Rash—Etoposide—lung cancer	7.2e-05	0.000525	CcSEcCtD
Toremifene—Dermatitis—Etoposide—lung cancer	7.2e-05	0.000525	CcSEcCtD
Toremifene—Headache—Etoposide—lung cancer	7.16e-05	0.000522	CcSEcCtD
Toremifene—Chest pain—Methotrexate—lung cancer	7.14e-05	0.00052	CcSEcCtD
Toremifene—Vomiting—Paclitaxel—lung cancer	7.12e-05	0.000519	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.09e-05	0.000517	CcSEcCtD
Toremifene—Rash—Paclitaxel—lung cancer	7.06e-05	0.000515	CcSEcCtD
Toremifene—Dermatitis—Paclitaxel—lung cancer	7.06e-05	0.000514	CcSEcCtD
Toremifene—Back pain—Doxorubicin—lung cancer	7.02e-05	0.000512	CcSEcCtD
Toremifene—Headache—Paclitaxel—lung cancer	7.02e-05	0.000512	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—lung cancer	6.84e-05	0.000499	CcSEcCtD
Toremifene—Asthenia—Docetaxel—lung cancer	6.81e-05	0.000497	CcSEcCtD
Toremifene—Nausea—Etoposide—lung cancer	6.79e-05	0.000495	CcSEcCtD
Toremifene—Pruritus—Docetaxel—lung cancer	6.72e-05	0.00049	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—lung cancer	6.71e-05	0.000489	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—lung cancer	6.7e-05	0.000488	CcSEcCtD
Toremifene—Nausea—Paclitaxel—lung cancer	6.65e-05	0.000485	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—lung cancer	6.65e-05	0.000485	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—lung cancer	6.62e-05	0.000482	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—lung cancer	6.52e-05	0.000475	CcSEcCtD
Toremifene—Anorexia—Methotrexate—lung cancer	6.52e-05	0.000475	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—lung cancer	6.5e-05	0.000474	CcSEcCtD
Toremifene—Dizziness—Docetaxel—lung cancer	6.28e-05	0.000458	CcSEcCtD
Toremifene—Insomnia—Methotrexate—lung cancer	6.19e-05	0.000451	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—lung cancer	6.18e-05	0.000451	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.14e-05	0.000447	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—lung cancer	6.1e-05	0.000445	CcSEcCtD
Toremifene—Vomiting—Docetaxel—lung cancer	6.04e-05	0.00044	CcSEcCtD
Toremifene—Rash—Docetaxel—lung cancer	5.99e-05	0.000436	CcSEcCtD
Toremifene—Dermatitis—Docetaxel—lung cancer	5.98e-05	0.000436	CcSEcCtD
Toremifene—Tamoxifen—ABCB1—lung cancer	5.97e-05	0.0244	CrCbGaD
Toremifene—Decreased appetite—Methotrexate—lung cancer	5.95e-05	0.000434	CcSEcCtD
Toremifene—Headache—Docetaxel—lung cancer	5.95e-05	0.000434	CcSEcCtD
Toremifene—Oedema—Doxorubicin—lung cancer	5.93e-05	0.000432	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—lung cancer	5.91e-05	0.000431	CcSEcCtD
Toremifene—Fatigue—Methotrexate—lung cancer	5.9e-05	0.00043	CcSEcCtD
Toremifene—Pain—Methotrexate—lung cancer	5.85e-05	0.000427	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—lung cancer	5.81e-05	0.000424	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—lung cancer	5.8e-05	0.000423	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—lung cancer	5.76e-05	0.00042	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—lung cancer	5.73e-05	0.000418	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—lung cancer	5.65e-05	0.000412	CcSEcCtD
Toremifene—Nausea—Docetaxel—lung cancer	5.64e-05	0.000411	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—lung cancer	5.36e-05	0.000391	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—lung cancer	5.28e-05	0.000385	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—lung cancer	5.15e-05	0.000375	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—lung cancer	5.12e-05	0.000373	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—lung cancer	5.11e-05	0.000372	CcSEcCtD
Toremifene—Constipation—Doxorubicin—lung cancer	5.07e-05	0.000369	CcSEcCtD
Toremifene—Pain—Doxorubicin—lung cancer	5.07e-05	0.000369	CcSEcCtD
Toremifene—Asthenia—Methotrexate—lung cancer	4.91e-05	0.000358	CcSEcCtD
Toremifene—Pruritus—Methotrexate—lung cancer	4.84e-05	0.000353	CcSEcCtD
Toremifene—Dizziness—Methotrexate—lung cancer	4.53e-05	0.00033	CcSEcCtD
Toremifene—Vomiting—Methotrexate—lung cancer	4.35e-05	0.000317	CcSEcCtD
Toremifene—Rash—Methotrexate—lung cancer	4.31e-05	0.000315	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—lung cancer	4.31e-05	0.000314	CcSEcCtD
Toremifene—Headache—Methotrexate—lung cancer	4.29e-05	0.000312	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—lung cancer	4.25e-05	0.00031	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—lung cancer	4.19e-05	0.000306	CcSEcCtD
Toremifene—Nausea—Methotrexate—lung cancer	4.06e-05	0.000296	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—lung cancer	3.92e-05	0.000286	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—lung cancer	3.77e-05	0.000275	CcSEcCtD
Toremifene—Rash—Doxorubicin—lung cancer	3.74e-05	0.000272	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—lung cancer	3.73e-05	0.000272	CcSEcCtD
Toremifene—Headache—Doxorubicin—lung cancer	3.71e-05	0.000271	CcSEcCtD
Toremifene—Nausea—Doxorubicin—lung cancer	3.52e-05	0.000257	CcSEcCtD
Toremifene—ESR1—Signaling Pathways—FGF9—lung cancer	1.26e-05	0.000169	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2A7—lung cancer	1.26e-05	0.000168	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NCOA3—lung cancer	1.25e-05	0.000167	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTA2—lung cancer	1.25e-05	0.000167	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.23e-05	0.000164	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SDC4—lung cancer	1.23e-05	0.000164	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD17B10—lung cancer	1.23e-05	0.000164	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ADCY1—lung cancer	1.22e-05	0.000163	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCG2—lung cancer	1.22e-05	0.000163	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—lung cancer	1.22e-05	0.000162	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTA1—lung cancer	1.21e-05	0.000161	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUNB—lung cancer	1.21e-05	0.000161	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.2e-05	0.00016	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HPGDS—lung cancer	1.2e-05	0.00016	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ENO2—lung cancer	1.2e-05	0.00016	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCC3—lung cancer	1.19e-05	0.000159	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPP2R1B—lung cancer	1.19e-05	0.000159	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.17e-05	0.000156	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTT1—lung cancer	1.16e-05	0.000155	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKR1C1—lung cancer	1.16e-05	0.000154	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2A6—lung cancer	1.15e-05	0.000153	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GCLC—lung cancer	1.15e-05	0.000153	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CKB—lung cancer	1.14e-05	0.000152	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.14e-05	0.000152	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—UGT1A1—lung cancer	1.12e-05	0.00015	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—RRM1—lung cancer	1.12e-05	0.00015	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA3—lung cancer	1.12e-05	0.00015	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.1e-05	0.000147	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STK11—lung cancer	1.1e-05	0.000146	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ENO1—lung cancer	1.09e-05	0.000145	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNG11—lung cancer	1.08e-05	0.000144	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.08e-05	0.000144	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CNDP2—lung cancer	1.07e-05	0.000143	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM2—lung cancer	1.07e-05	0.000143	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.07e-05	0.000143	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.06e-05	0.000142	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FOXO3—lung cancer	1.06e-05	0.000141	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—B4GALT5—lung cancer	1.05e-05	0.000141	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTMR3—lung cancer	1.04e-05	0.000139	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALDOA—lung cancer	1.03e-05	0.000138	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA4—lung cancer	1.03e-05	0.000137	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.02e-05	0.000137	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PGAM1—lung cancer	1.02e-05	0.000136	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1e-05	0.000134	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOA3—lung cancer	1e-05	0.000134	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA2—lung cancer	9.99e-06	0.000133	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AVP—lung cancer	9.91e-06	0.000132	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CREBBP—lung cancer	9.87e-06	0.000132	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2E1—lung cancer	9.74e-06	0.00013	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCG2—lung cancer	9.73e-06	0.00013	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADCY1—lung cancer	9.73e-06	0.00013	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2A7—lung cancer	9.71e-06	0.00013	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA1—lung cancer	9.64e-06	0.000129	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NQO1—lung cancer	9.63e-06	0.000129	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HPGDS—lung cancer	9.54e-06	0.000127	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ENO2—lung cancer	9.54e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1R—lung cancer	9.54e-06	0.000127	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCC3—lung cancer	9.53e-06	0.000127	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SDC4—lung cancer	9.5e-06	0.000127	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPP2R1B—lung cancer	9.48e-06	0.000127	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.43e-06	0.000126	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HES1—lung cancer	9.37e-06	0.000125	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.35e-06	0.000125	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTT1—lung cancer	9.26e-06	0.000124	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKR1C1—lung cancer	9.23e-06	0.000123	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCLC—lung cancer	9.15e-06	0.000122	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2A6—lung cancer	9.15e-06	0.000122	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.98e-06	0.00012	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—UGT1A1—lung cancer	8.96e-06	0.00012	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—STK11—lung cancer	8.68e-06	0.000116	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ENO1—lung cancer	8.68e-06	0.000116	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.67e-06	0.000116	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RRM1—lung cancer	8.65e-06	0.000115	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA3—lung cancer	8.65e-06	0.000115	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNG11—lung cancer	8.64e-06	0.000115	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.6e-06	0.000115	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB3—lung cancer	8.57e-06	0.000114	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDOA—lung cancer	8.23e-06	0.00011	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—lung cancer	8.21e-06	0.00011	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.15e-06	0.000109	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—B4GALT5—lung cancer	8.13e-06	0.000109	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	8.11e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—lung cancer	8.03e-06	0.000107	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOA3—lung cancer	7.99e-06	0.000107	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGFR1—lung cancer	7.97e-06	0.000106	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA4—lung cancer	7.91e-06	0.000106	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—lung cancer	7.85e-06	0.000105	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.85e-06	0.000105	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAT—lung cancer	7.82e-06	0.000104	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2E1—lung cancer	7.78e-06	0.000104	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.77e-06	0.000104	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADCY1—lung cancer	7.77e-06	0.000104	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCG2—lung cancer	7.77e-06	0.000104	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA2—lung cancer	7.71e-06	0.000103	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NQO1—lung cancer	7.69e-06	0.000103	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HPGDS—lung cancer	7.62e-06	0.000102	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ENO2—lung cancer	7.62e-06	0.000102	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCB1—lung cancer	7.61e-06	0.000102	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOA1—lung cancer	7.58e-06	0.000101	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPP2R1B—lung cancer	7.57e-06	0.000101	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KDR—lung cancer	7.51e-06	0.0001	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.47e-06	9.97e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TYMS—lung cancer	7.47e-06	9.97e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA1—lung cancer	7.44e-06	9.93e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—lung cancer	7.39e-06	9.87e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—lung cancer	7.38e-06	9.86e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCC3—lung cancer	7.36e-06	9.82e-05	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	7.34e-06	9.79e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2A6—lung cancer	7.31e-06	9.75e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCLC—lung cancer	7.31e-06	9.75e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.28e-06	9.71e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKR1C1—lung cancer	7.12e-06	9.51e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ERCC2—lung cancer	6.94e-06	9.27e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—STK11—lung cancer	6.94e-06	9.26e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ENO1—lung cancer	6.93e-06	9.24e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KIT—lung cancer	6.92e-06	9.24e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APC—lung cancer	6.92e-06	9.24e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—lung cancer	6.92e-06	9.24e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UGT1A1—lung cancer	6.92e-06	9.23e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.9e-06	9.21e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGF—lung cancer	6.84e-06	9.13e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.81e-06	9.09e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNG11—lung cancer	6.67e-06	8.9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—lung cancer	6.59e-06	8.79e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—lung cancer	6.5e-06	8.68e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6R—lung cancer	6.43e-06	8.58e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—lung cancer	6.42e-06	8.57e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CREBBP—lung cancer	6.42e-06	8.56e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDOA—lung cancer	6.35e-06	8.48e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAT—lung cancer	6.24e-06	8.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2E1—lung cancer	6.21e-06	8.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOA3—lung cancer	6.16e-06	8.23e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NQO1—lung cancer	6.14e-06	8.2e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAP2K1—lung cancer	6.12e-06	8.17e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—lung cancer	6.08e-06	8.12e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK3—lung cancer	6.02e-06	8.04e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.01e-06	8.03e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOA1—lung cancer	6e-06	8.02e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADCY1—lung cancer	6e-06	8e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCG2—lung cancer	6e-06	8e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TYMS—lung cancer	5.97e-06	7.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.96e-06	7.96e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—lung cancer	5.9e-06	7.87e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HPGDS—lung cancer	5.88e-06	7.85e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ENO2—lung cancer	5.88e-06	7.85e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—lung cancer	5.86e-06	7.82e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.84e-06	7.8e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.75e-06	7.68e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—lung cancer	5.7e-06	7.61e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCLC—lung cancer	5.64e-06	7.53e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2A6—lung cancer	5.64e-06	7.53e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A1—lung cancer	5.59e-06	7.46e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ERCC2—lung cancer	5.54e-06	7.4e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—STK11—lung cancer	5.54e-06	7.39e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—lung cancer	5.48e-06	7.32e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MDM2—lung cancer	5.45e-06	7.28e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAF1—lung cancer	5.43e-06	7.25e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB2—lung cancer	5.37e-06	7.17e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ENO1—lung cancer	5.34e-06	7.13e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—lung cancer	5.3e-06	7.08e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MTOR—lung cancer	5.3e-06	7.08e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—lung cancer	5.22e-06	6.97e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.2e-06	6.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—lung cancer	5.12e-06	6.84e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—lung cancer	5.1e-06	6.8e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CREBBP—lung cancer	5.08e-06	6.79e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAT—lung cancer	4.98e-06	6.65e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.96e-06	6.62e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—lung cancer	4.88e-06	6.51e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—lung cancer	4.87e-06	6.5e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCB1—lung cancer	4.85e-06	6.47e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—lung cancer	4.82e-06	6.43e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA1—lung cancer	4.8e-06	6.4e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2E1—lung cancer	4.79e-06	6.4e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TYMS—lung cancer	4.76e-06	6.36e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—lung cancer	4.76e-06	6.35e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—lung cancer	4.75e-06	6.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NQO1—lung cancer	4.74e-06	6.33e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUN—lung cancer	4.74e-06	6.32e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—lung cancer	4.71e-06	6.28e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—lung cancer	4.61e-06	6.15e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—lung cancer	4.59e-06	6.13e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—lung cancer	4.58e-06	6.12e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1A1—lung cancer	4.46e-06	5.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ERCC2—lung cancer	4.43e-06	5.91e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—lung cancer	4.38e-06	5.85e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EP300—lung cancer	4.37e-06	5.83e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—STK11—lung cancer	4.27e-06	5.7e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SRC—lung cancer	4.25e-06	5.67e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—lung cancer	4.2e-06	5.61e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—lung cancer	4.17e-06	5.56e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—lung cancer	4.16e-06	5.56e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—lung cancer	4.14e-06	5.52e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—lung cancer	4.1e-06	5.47e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRAS—lung cancer	4.09e-06	5.46e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—lung cancer	4.06e-06	5.42e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CREBBP—lung cancer	4.06e-06	5.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—lung cancer	3.95e-06	5.28e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK3—lung cancer	3.91e-06	5.23e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—lung cancer	3.85e-06	5.14e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAT—lung cancer	3.85e-06	5.14e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA1—lung cancer	3.83e-06	5.11e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—lung cancer	3.81e-06	5.08e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—lung cancer	3.8e-06	5.07e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCB1—lung cancer	3.74e-06	5e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—lung cancer	3.72e-06	4.97e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TYMS—lung cancer	3.68e-06	4.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.67e-06	4.89e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—lung cancer	3.63e-06	4.85e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—lung cancer	3.63e-06	4.85e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—lung cancer	3.52e-06	4.7e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—lung cancer	3.5e-06	4.67e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—EP300—lung cancer	3.46e-06	4.62e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A1—lung cancer	3.44e-06	4.6e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ERCC2—lung cancer	3.42e-06	4.56e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—lung cancer	3.36e-06	4.48e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—lung cancer	3.33e-06	4.44e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—lung cancer	3.32e-06	4.44e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CREBBP—lung cancer	3.24e-06	4.33e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—lung cancer	3.23e-06	4.32e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—lung cancer	3.13e-06	4.17e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—lung cancer	3.07e-06	4.1e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—lung cancer	3.03e-06	4.05e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—lung cancer	2.99e-06	3.99e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA1—lung cancer	2.95e-06	3.94e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—lung cancer	2.9e-06	3.87e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—lung cancer	2.86e-06	3.82e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—EP300—lung cancer	2.76e-06	3.69e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—lung cancer	2.7e-06	3.6e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—lung cancer	2.68e-06	3.58e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—lung cancer	2.65e-06	3.54e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—lung cancer	2.64e-06	3.53e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—lung cancer	2.57e-06	3.43e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—lung cancer	2.56e-06	3.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CREBBP—lung cancer	2.5e-06	3.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—lung cancer	2.37e-06	3.17e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—lung cancer	2.34e-06	3.13e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—lung cancer	2.31e-06	3.09e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—EP300—lung cancer	2.21e-06	2.95e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—lung cancer	2.09e-06	2.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—lung cancer	2.07e-06	2.76e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—lung cancer	2.05e-06	2.73e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—lung cancer	2.05e-06	2.73e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—lung cancer	1.79e-06	2.38e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—EP300—lung cancer	1.7e-06	2.27e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—lung cancer	1.67e-06	2.23e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—lung cancer	1.63e-06	2.18e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—lung cancer	1.33e-06	1.78e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—lung cancer	1.26e-06	1.68e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—lung cancer	1.03e-06	1.37e-05	CbGpPWpGaD
